Ten-Year Relative Survival and Causes of Death in Elderly Patients Treated With R-CHOP or CHOP in the GELA LNH-985 Trial
Authors:
- Nicolas MounierNMNicolas Mounier
- Natacha HeutteNHNatacha Heutte
- Catherine ThieblemontCTCatherine Thieblemont
- Josette BriereJBJosette Briere
- Philippe GaulardPGPhilippe Gaulard
- Pierre FeugierPFPierre Feugier
- Hervé GhesquieresHGHervé Ghesquieres
- Eric Van Den NesteENEric Van Den Neste
- Daniela RobuDRDaniela Robu
- Herve TillyHTHerve Tilly
- Reda BouabdallahRBReda Bouabdallah
- Violaine SafarVSViolaine Safar
- 1 June 2012
- journal article
- research article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 12 (3) , 151-154
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Long-Term Complications of Lymphoma and Its TreatmentJournal of Clinical Oncology, 2011
- Risk for second malignancies in non-Hodgkin’s lymphoma survivors: a meta-analysisAnnals of Oncology, 2011
- Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'AdulteBlood, 2010
- Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort studyHaematologica, 2008
- Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)The Lancet Oncology, 2008
- Risk of Second Malignancy After Non-Hodgkin's Lymphoma: A British Cohort StudyJournal of Clinical Oncology, 2006
- Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'AdulteJournal of Clinical Oncology, 2005
- Regression models for relative survivalStatistics in Medicine, 2003
- Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patientsBlood, 2003
- CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell LymphomaNew England Journal of Medicine, 2002